Cargando…
Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome
BACKGROUND: Prader–Willi syndrome (PWS) is a rare and multisystemic genetic disorder that is characterized by severe hypotonia, hyperphagia, short stature, and global developmental delay. Although early recombinant human growth hormone (rhGH) treatment has been proven to rescue some symptoms and bri...
Autores principales: | Gao, Ying, Yang, Li-Li, Dai, Yang-Li, Shen, Zheng, Zhou, Qiong, Zou, Chao-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906936/ https://www.ncbi.nlm.nih.gov/pubmed/36750945 http://dx.doi.org/10.1186/s13023-023-02615-7 |
Ejemplares similares
-
Prader-Willi Syndrome and Growth Hormone Deficiency
por: Aycan, Zehra, et al.
Publicado: (2014) -
Growth Hormone Therapy in Adults with Prader-Willi Syndrome
por: Vogt, Karen S., et al.
Publicado: (2015) -
Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader–Willi syndrome
por: Cheng, Ruo-Qian, et al.
Publicado: (2022) -
Perinatal features of Prader-Willi syndrome: a Chinese cohort of 134 patients
por: Yang, Lili, et al.
Publicado: (2020) -
Growth hormone therapy for Prader–willi syndrome: challenges and solutions
por: Grugni, Graziano, et al.
Publicado: (2016)